Trial Profile
Real-life" safety and efficacy of belimumab added to standard therapy in patents with Systemic Lupus Erythematosus in five Israeli medical centers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2018
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- 18 Mar 2018 New trial record